Cancer Incidence and Mortality among Non-Hispanic Blacks, Kings County (Brooklyn), 2005-2009
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males | Females | Males | Females | |||||||||
| Average Annual Cases | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Cases | Rate per 100,000 Females | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Females | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 1777.6 | 593.8 | 13.0 | 1814.0 | 369.4 | 7.7 | 540.2 | 202.4 | 8.2 | 670.2 | 138.6 | 4.7 |
| Oral cavity and pharynx | 44.0 | 13.1 | 1.8 | 25.0 | 5.0 | 0.9 | 15.8 | 4.8 | 1.1 | 6.2 | 1.2 | 0.4 |
| Esophagus | 27.0 | 8.9 | 1.6 | 14.4 | 3.0 | 0.7 | 22.2 | 7.2 | 1.4 | 9.8 | 1.9 | 0.5 |
| Stomach | 50.0 | 19.0 | 2.5 | 43.4 | 9.3 | 1.2 | 26.0 | 10.6 | 1.9 | 22.8 | 5.0 | 0.9 |
| Colorectal | 172.4 | 59.8 | 4.2 | 209.6 | 43.3 | 2.6 | 64.8 | 23.9 | 2.8 | 75.4 | 15.8 | 1.6 |
| Colon excluding rectum | 129.2 | 45.7 | 3.8 | 159.8 | 33.1 | 2.3 | 56.2 | 21.0 | 2.6 | 65.0 | 13.7 | 1.5 |
| Rectum & rectosigmoid | 43.2 | 14.1 | 2.0 | 49.8 | 10.2 | 1.3 | 8.6 | 3.0 | 0.9 | 10.4 | 2.1 | 0.6 |
| Liver / intrahepatic bile duct | 42.2 | 13.2 | 1.9 | 17.6 | 3.5 | 0.7 | 27.6 | 9.0 | 1.6 | 16.2 | 3.4 | 0.7 |
| Pancreas | 37.6 | 13.7 | 2.1 | 49.6 | 10.4 | 1.3 | 30.2 | 10.8 | 1.8 | 40.4 | 8.6 | 1.2 |
| Larynx | 24.6 | 8.0 | 1.5 | 8.0 | 1.5 | 0.5 | 10.8 | 3.7 | 1.0 | 3.4 | 0.7 | 0.3 |
| Lung and bronchus | 178.0 | 61.2 | 4.2 | 168.4 | 34.5 | 2.4 | 123.2 | 42.6 | 3.5 | 111.0 | 23.0 | 1.9 |
| Melanoma of the skin | 3.6 | 1.4 | 0.7 | 5.6 | 1.1 | 0.4 | 0.8 | 0.2 | 0.2 | 1.6 | 0.3 | 0.2 |
| Female breast | 526.0 | 106.0 | 4.1 | 143.2 | 29.1 | 2.2 | ||||||
| Cervix uteri | 79.4 | 16.0 | 1.6 | 26.4 | 5.3 | 0.9 | ||||||
| Corpus uterus and NOS | 154.2 | 30.2 | 2.2 | 43.8 | 8.9 | 1.2 | ||||||
| Ovary | 48.6 | 9.9 | 1.3 | 29.0 | 5.9 | 1.0 | ||||||
| Prostate | 810.4 | 268.6 | 8.7 | 103.8 | 49.2 | 4.5 | ||||||
| Testis | 5.4 | 1.5 | 0.6 | 0.2 | 0.1 | 0.1 | ||||||
| Urinary bladder (incl. in situ) | 38.6 | 14.6 | 2.2 | 28.0 | 6.2 | 1.0 | 8.2 | 3.7 | 1.2 | 8.6 | 1.9 | 0.6 |
| Kidney and renal pelvis | 46.2 | 14.3 | 1.9 | 36.0 | 7.3 | 1.1 | 7.8 | 2.9 | 1.0 | 5.6 | 1.2 | 0.4 |
| Brain and other nervous system | 14.4 | 4.1 | 1.0 | 16.8 | 3.4 | 0.7 | 8.0 | 2.5 | 0.8 | 7.0 | 1.4 | 0.5 |
| Thyroid | 10.0 | 3.1 | 0.9 | 61.6 | 12.2 | 1.4 | 2.2 | 1.0 | 0.6 | 3.4 | 0.7 | 0.3 |
| Hodgkin lymphoma | 12.6 | 3.4 | 0.9 | 11.6 | 2.4 | 0.6 | 1.0 | 0.3 | 0.2 | 0.8 | 0.2 | 0.2 |
| Non-Hodgkin lymphomas | 62.0 | 18.9 | 2.2 | 62.2 | 12.8 | 1.4 | 16.0 | 5.4 | 1.2 | 19.4 | 3.9 | 0.8 |
| Multiple myeloma | 39.6 | 13.8 | 2.0 | 48.2 | 10.0 | 1.3 | 12.0 | 4.0 | 1.1 | 16.2 | 3.4 | 0.8 |
| Leukemias | 30.4 | 10.3 | 1.8 | 31.6 | 6.5 | 1.0 | 14.6 | 4.9 | 1.2 | 15.2 | 3.2 | 0.7 |
Notes
- Incidence data are provisional, November 2011.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
